Concordant KRAS mutations in primary and metastatic colorectal cancer tissue specimens: a meta-analysis and systematic review (Q38052918)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 17 October 2012

Language	Label	Description	Also known as
English	Concordant KRAS mutations in primary and metastatic colorectal cancer tissue specimens: a meta-analysis and systematic review	scientific article published on 17 October 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

0 references

Concordant KRAS mutations in primary and metastatic colorectal cancer tissue specimens: a meta-analysis and systematic review (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

metastatic colon cancer

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Cheng-Bo Han

1

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Fan Li

2

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Jie-Tao Ma

3

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Hua-Wei Zou

4

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

publication date

17 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Cancer Investigation

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

741-747

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Expression of epidermal growth factor-receptor related protein (ERRP) in human colorectal carcinogenesis.

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.732159

21 January 2018

Cetuximab: an epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.732159

21 January 2018

Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.732159

21 January 2018

Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.732159

21 January 2018

Cetuximab and panitumumab in KRAS wild-type colorectal cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.732159

21 January 2018

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.732159

21 January 2018

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.732159

21 January 2018

Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.732159

21 January 2018

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.732159

21 January 2018

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.732159

21 January 2018

PTEN status in advanced colorectal cancer treated with cetuximab.

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.732159

21 January 2018

KRAS mutations in primary colorectal cancer tumors and related metastases: a potential role in prediction of lung metastasis

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.732159

21 January 2018

K-Ras mutations and treatment outcome in colorectal cancer patients receiving exclusive fluoropyrimidine therapy.

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.732159

21 January 2018

KRAS and BRAF mutational status in primary colorectal tumors and related metastatic sites: biological and clinical implications

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.732159

21 January 2018

KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients.

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.732159

21 January 2018

Stability of K-ras mutations throughout the natural history of human colorectal cancer

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.732159

21 January 2018

PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.732159

21 January 2018

Differing deregulation of EGFR and downstream proteins in primary colorectal cancer and related metastatic sites may be clinically relevant

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.732159

21 January 2018

Analysis of KRAS, BRAF, PTEN, IGF1R, EGFR intron 1 CA status in both primary tumors and paired metastases in determining benefit from cetuximab therapy in colon cancer.

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.732159

21 January 2018

Heterogeneity of KRAS status may explain the subset of discordant KRAS status between primary and metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.732159

21 January 2018

Allelotyping analyses of synchronous primary and metastasis CIN colon cancers identified different subtypes.

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.732159

21 January 2018

Molecular changes in the Ki-ras and APC genes in primary colorectal carcinoma and synchronous metastases compared with the findings in accompanying adenomas

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.732159

21 January 2018

Genetic alterations during colorectal-tumor development

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.732159

21 January 2018

High sensitivity of both sequencing and real-time PCR analysis of KRAS mutations in colorectal cancer tissue

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.732159

21 January 2018

A progression puzzle

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.732159

21 January 2018

PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.732159

21 January 2018

KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.732159

21 January 2018

KRASMutations and Anti–Epidermal Growth Factor Receptor Therapy in Colorectal Cancer With Lymph Node Metastases

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.732159

21 January 2018

Identifiers

10.3109/07357907.2012.732159

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38052918&oldid=2177400697"